CompletedNCT04993560

Safety and Efficacy of COVID-19 Prime-boost Vaccine in Bahrain

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Royal College of Surgeons in Ireland - Medical University of Bahrain
Principal Investigator
Manaf AlQahtani, Dr.
Royal College of Surgeons in Ireland - Bahrain
Intervention
BBIBP-CorV(biological)
Enrollment
305 target
Eligibility
21 years · All sexes
Timeline
20212021

Study locations (1)

Collaborators

The National Taskforce for Combatting COVID-19- Kingdom of Bahrain · Bahrain Defence Force Royal Medical Services · Ministry of Health, Bahrain · Bahrain International Exhibition & Convention Centre

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04993560 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials